Copyright for articles published in this journal is retained by the journal.
Author Biographies
O Ghoundale
Service d’urologie. Hôpital militaire Avicenne, Marrakech
Y El Harrech
Service d’urologie. Hôpital militaire Avicenne, Marrakech
N Abakka
Service d’urologie. Hôpital militaire Avicenne, Marrakech
J El Anzaoui
Service d’urologie. Hôpital militaire Avicenne, Marrakech
S Tamouh
Service d’urologie. Hôpital militaire Avicenne, Marrakech
D Touiti
Service d’urologie. Hôpital militaire Avicenne, Marrakech
Main Article Content
La nephrolithotomie sur rein unique: a propos de vingt cas
O Ghoundale
Y El Harrech
N Abakka
J El Anzaoui
S Tamouh
D Touiti
Abstract
Introduction: Percutaneous nephrolithotomy (PCNL) is the most important therapeutic alternative in the management of large or complex renal calculi. Through a series of 20 patients, we study the feasibility and morbidity of this technique in a solitary kidney. Patients and methods: we retrospectively reviewed a series of twenty patients with a calculus in a solitary kidney during a 9-year period, all treated with (PCNL). The results were analyzed emphasizing complications with a special focus on the evolution of renal function. Results: Patients were divided into two groups depending on the size of the renal stone. The average age was 39 years (23-56 years). Pain was the dominant symptom, found in 60% of the patients. The stone free rate was 87.5% in group 1 and 84% in group 2. Further complementary treatment was necessary in 3 cases. Preoperative renal function was normal in 75% of the cases. After a moderate deterioration in the immediate postoperative period, renal function improved at one month follow up, and this improvement remained sustained for one year. Conclusion: The PCNL in a solitary kidney is safe and the results are comparable to those obtained with two functioning kidneys. Renal function is particularly not degraded in the medium or the long term.
Keywords: Urolithiasis; Solitary kidney; Percutaneous nephrolithotomy; Renal function
African Journal of Urology (2013) 19, 102–106
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.